Covidien Ltd Recalls Syringes Posing Risk to Diabetics

WASHINGTON, Nov 5 (Reuters) - U.S. health officials warned doctors and patients on Wednesday that Covidien Ltd was recalling nearly half a million single-use syringes that could pose a serious risk to diabetics.

MORE ON THIS TOPIC